...
首页> 外文期刊>Biomaterials >In vivo cancer targeting via glycopolyester nanoparticle mediated metabolic cell labeling followed by click reaction
【24h】

In vivo cancer targeting via glycopolyester nanoparticle mediated metabolic cell labeling followed by click reaction

机译:在体内癌症通过甘甘油聚酯纳米粒子介导的代谢细胞标记,然后点击反应

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We developed glycopolyesters (GPs) via azido-sugar initiated ring-opening polymerization of O-carboxyanhy-drides (OCAs) and achieved efficient in vivo cancer targeting via GP-nanoparticle (GP-NP) mediated metabolic cell labeling followed by Click reaction. GP-NP shows controlled release of azido-sugars and can efficiently label LS174T colon cancer cells with azido groups in tumor-bearing mice. The exogenously introduced azido groups render excellent in vivo cancer targeting and retention of dibenzocyclooctyne-Cy5 (DBCO-Cy5) with an increasing tumor retention enhancement over time (68% at 6h, 105% at 24 h, and 191% at 48 h) compared to control mice without azido labeling. The tumor accumulation of DBCO-doxorubicin is also significantly enhanced in GP-NP pretreated mice, resulting in improved in vivo anticancer efficacy. This study, for the first time, proposes the use of azido-sugar initiated polymerization of OCAs to form sugar delivery vehicles with high stability and controlled release, and demonstrates the increasing tumor targeting effect of DBCO-cargo over time by azido-modified tumor cells.
机译:我们通过Azido-糖开始O-羧基-Vers(OCAs)的开环聚合来开发糖蛋白酶(GPS),并通过GP-NANIP颗粒(GP-NP)介导的代谢细胞标记鉴定靶向的体内癌症效率,然后点击反应。 GP-NP显示氮杂糖的受控释放,可以用携带肿瘤小鼠的氮杂族基团将LS174T结肠癌细胞有效地标记。外源性引入的氮杂族基团具有优异的体内癌症靶向和依赖二苯并苯并亮胞菌-CY5(DBCO-CY5),随着时间的推移增加(6小时,24小时,105%,48小时,191%的6小时,105%)进行比较控制没有ziido标记的小鼠。在GP-NP预处理小鼠中也显着增强了DBCO-Doxorubicin的肿瘤积累,导致体内抗癌疗效得到改善。本研究首次提出使用奥兹醛 - 糖的ocas的聚合,形成具有高稳定性和控制释放的糖递送载体,并通过αzido修饰的肿瘤细胞显示DBCO-货物随着时间的推移增加的肿瘤靶向效应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号